Advertisement
Research Article| Volume 357, ISSUE 1-2, P270-275, October 15, 2015

Download started.

Ok

The role of p38MAPK signal pathway in the neuroprotective mechanism of limb postconditioning against rat cerebral ischemia/reperfusion injury

  • Hao Li
    Affiliations
    Southern Medical University, Guangzhou, Guangdong Province, China

    Department of Neurology, Guangdong Neuroscience Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, Guangdong Province, China
    Search for articles by this author
  • Suxian Zhou
    Affiliations
    Department of Endocrinology, Affiliated Hospital of Guilin Medical University, Guilin, China
    Search for articles by this author
  • Lan Wu
    Affiliations
    Department of Neurology, Affiliated Hospital of Guilin Medical University, Guilin, China
    Search for articles by this author
  • Kaixiang Liu
    Affiliations
    Department of Neurology, Affiliated Hospital of Guilin Medical University, Guilin, China
    Search for articles by this author
  • Yuhu Zhang
    Affiliations
    Department of Neurology, Guangdong Neuroscience Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, Guangdong Province, China
    Search for articles by this author
  • Guixian Ma
    Affiliations
    Department of Neurology, Guangdong Neuroscience Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, Guangdong Province, China
    Search for articles by this author
  • Lijuan Wang
    Correspondence
    Corresponding author at: Department of Neurology, Guangdong Neuroscience Institute, Guangdong General Hospital , Guangdong Academy of Medical Sciences, 106 Zhongshan RdII, Guangzhou, Guangdong Province 510080, China.
    Affiliations
    Department of Neurology, Guangdong Neuroscience Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, Guangdong Province, China
    Search for articles by this author
Published:August 05, 2015DOI:https://doi.org/10.1016/j.jns.2015.08.004

      Highlights

      • Limb ischemia postconditioning (LPostC) has showed the neuroprotective effects in cerebral ischemia/reperfusion rats.
      • LPostC has decreased the neuronal apoptosis in ischemia/reperfusion.
      • LPostC or SB203580 (p38 MAPK inhibitor) has inhibited the activation of p38 and ATF-2 in cerebral ischemia/reperfusion rats.
      • The neuroprotective effects of LPostC may be related to its inhibiting p38-ATF-2 pathway.

      Abstract

      It has been reported that remote ischemic postconditioning was able to protect from a harmful ischemia occurring in brain. In the present study, we investigated the role of p38 MAPK signal pathway in the process of neuroprotection and anti-apoptosis following remote limb ischemic postconditioning on rat focal cerebral ischemia/reperfusion (I/R) model. Male Sprague–Dawley rats were divided randomly into four groups: the sham-operated group, I/R group, limb ischemic postconditioning (LPostC) group, and LPostC + SB203580 (p38 MAPK inhibitor) group. Focal ischemia was induced by transient middle cerebral artery occlusion. Limb ischemic postconditioning was implemented by brief cycles of femoral artery occlusion. At 24 h after modeling, we analyzed the neurological deficit score, assessed the cerebral tissue morphology by H-E staining, and evaluated neuronal apoptosis by TUNEL staining. The protein expression levels of p-p38 or p-ATF2 (phospho-activating transcription factor 2) in the penumbra region were detected by western blotting or immunohistochemical staining. Our findings revealed that LPostC relieved cerebral ischemia/reperfusion injury by decreasing neurological score, improving neuronal morphological changes in the ischemic penumbra area, and reducing neuronal apoptosis. In addition, LPostC or LPostC + SB203580 attenuated the increase in p-p38 and p-ATF2 levels in ischemia/reperfusion brain tissue. These results indicate that the protective effects of LPostC against cerebral I/R injury may be related to the attenuation of neuronal apoptosis and the suppression of p38 MAPK-ATF2 pathway.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Nour M.
        • Scalzo F.
        • Liebeskind D.S.
        Ischemia–reperfusion injury in stroke.
        Interv. Neurol. 2013; 1: 185-199
        • Eltzschig H.K.
        • Eckle T.
        Ischemia and reperfusion—from mechanism to translation.
        Nat. Med. 2011; 17: 1391-1401
        • Durukan A.
        • Tatlisumak T.
        Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia.
        Pharmacol. Biochem. Behav. 2007; 87: 179-197
        • Rodrigo R.
        • Fernandez-Gajardo R.
        • Gutierrez R.
        • Matamala J.M.
        • Carrasco R.
        • Miranda-Merchak A.
        • et al.
        Oxidative stress and pathophysiology of ischemic stroke: novel therapeutic opportunities.
        CNS Neurol. Disord.: Drug Targets. 2013; 12: 698-714
        • Emberson J.
        • Lees K.R.
        • Lyden P.
        • Blackwell L.
        • Albers G.
        • Bluhmki E.
        • et al.
        Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials.
        Lancet. 2014; 384: 1929-1935
        • Schmidt A.
        • Minnerup J.
        • Kleinschnitz C.
        Emerging neuroprotective drugs for the treatment of acute ischaemic stroke.
        Expert Opin. Emerg. Drugs. 2013; 18: 109-120
        • Chen F.
        • Qi Z.
        • Luo Y.
        • Hinchliffe T.
        • Ding G.
        • Xia Y.
        • et al.
        Non-pharmaceutical therapies for stroke: mechanisms and clinical implications.
        Prog. Neurobiol. 2014; 115: 246-269
        • Dezfulian C.
        • Garrett M.
        • Gonzalez N.R.
        Clinical application of preconditioning and postconditioning to achieve neuroprotection.
        Transl. Stroke Res,. 2013; 4: 19-24
        • Stetler R.A.
        • Leak R.K.
        • Gan Y.
        • Li P.
        • Zhang F.
        • Hu X.
        • et al.
        Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance.
        Prog. Neurobiol. 2014; 114: 58-83
        • Heusch G.
        • Botker H.E.
        • Przyklenk K.
        • Redington A.
        • Yellon D.
        Remote ischemic conditioning.
        J. Am. Coll. Cardiol. 2015; 65: 177-195
        • Hess D.C.
        • Hoda M.N.
        • Bhatia K.
        Remote limb perconditioning and postconditioning: will it translate into a promising treatment for acute stroke?.
        Stroke. 2013; 44: 1191-1197
        • Tamareille S.
        • Mateus V.
        • Ghaboura N.
        • Jeanneteau J.
        • Croue A.
        • Henrion D.
        • et al.
        RISK and SAFE signaling pathway interactions in remote limb ischemic perconditioning in combination with local ischemic postconditioning.
        Basic Res. Cardiol. 2011; 106: 1329-1339
        • Cheng Z.
        • Li L.
        • Mo X.
        • Zhang L.
        • Xie Y.
        • Guo Q.
        • et al.
        Non-invasive remote limb ischemic postconditioning protects rats against focal cerebral ischemia by upregulating STAT3 and reducing apoptosis.
        Int. J. Mol. Med. 2014; 34: 957-966
        • Longa E.Z.
        • Weinstein P.R.
        • Carlson S.
        • Cummins R.
        Reversible middle cerebral artery occlusion without craniectomy in rats.
        Stroke. 1989; 20: 84-91
        • Zhao H.
        • Ren C.
        • Chen X.
        • Shen J.
        From rapid to delayed and remote postconditioning: the evolving concept of ischemic postconditioning in brain ischemia.
        Curr. Drug Targets. 2012; 13: 173-187
        • Duch A.
        • de Nadal E.
        • Posas F.
        The p38 and Hog1 SAPKs control cell cycle progression in response to environmental stresses.
        FEBS Lett. 2012; 586: 2925-2931
        • Takeda K.
        • Ichijo H.
        Neuronal p38 MAPK signalling: an emerging regulator of cell fate and function in the nervous system.
        Genes Cells. 2002; 7: 1099-1111
        • Wang W.
        • Tang L.
        • Li Y.
        • Wang Y.
        Biochanin A protects against focal cerebral ischemia/reperfusion in rats via inhibition of p38-mediated inflammatory responses.
        J. Neurol. Sci. 2015; 348: 121-125
        • Strassburger M.
        • Braun H.
        • Reymann K.G.
        Anti-inflammatory treatment with the p38 mitogen-activated protein kinase inhibitor SB239063 is neuroprotective, decreases the number of activated microglia and facilitates neurogenesis in oxygen–glucose-deprived hippocampal slice cultures.
        Eur. J. Pharmacol. 2008; 592: 55-61
        • Liu X.W.
        • Ji E.F.
        • He P.
        • Xing R.X.
        • Tian B.X.
        • Li X.D.
        Protective effects of the p38 MAPK inhibitor SB203580 on NMDA-induced injury in primary cerebral cortical neurons.
        Mol. Med. Rep. 2014; 10: 1942-1948
        • Gozdecka M.
        • Breitwieser W.
        The roles of ATF2 (activating transcription factor 2) in tumorigenesis.
        Biochem. Soc. Trans. 2012; 40: 230-234
        • Hu B.R.
        • Fux C.M.
        • Martone M.E.
        • Zivin J.A.
        • Ellisman M.H.
        Persistent phosphorylation of cyclic AMP responsive element-binding protein and activating transcription factor-2 transcription factors following transient cerebral ischemia in rat brain.
        Neuroscience. 1999; 89: 437-452
        • Seong K.H.
        • Maekawa T.
        • Ishii S.
        Inheritance and memory of stress-induced epigenome change: roles played by the ATF-2 family of transcription factors.
        Genes Cells. 2012; 17: 249-263
        • Morton S.
        • Davis R.J.
        • Cohen P.
        Signalling pathways involved in multisite phosphorylation of the transcription factor ATF-2.
        FEBS Lett. 2004; 572: 177-183
        • Ma Q.
        • Li X.
        • Vale-Cruz D.
        • Brown M.L.
        • Beier F.
        • LuValle P.
        Activating transcription factor 2 controls Bcl-2 promoter activity in growth plate chondrocytes.
        J. Cell. Biochem. 2007; 101: 477-487
        • Leppa S.
        • Eriksson M.
        • Saffrich R.
        • Ansorge W.
        • Bohmann D.
        Complex functions of AP-1 transcription factors in differentiation and survival of PC12 cells.
        Mol. Cell. Biol. 2001; 21: 4369-4378